Previous 10 | Next 10 |
Lee Enterprises (NYSE: LEE ) +55% to acquire BH Media Group’s publications and The Buffalo News for $140M. More news on: Lee Enterprises, Incorporated, Hepion Pharmaceuticals, Inc., Genprex, Inc., Stocks on the move, , Read more ...
Are Any of These Penny Stocks On Your Watch List This Week? Finding the best penny stocks to buy , let alone the best penny stocks to watch can be a difficult thing to do. It’s not a matter of finding the companies either. But rather researching the finer details of what could drive ...
Volatility In The Market Is Good For Penny Stocks If you’re reading this penny stocks article right now, you likely saw the hit that the broader markets took over the weekend. Last week the S&P 500 declined significantly following more bad news from the spread of coronavirus into ...
Agile Therapeutics, Inc. (AGRX) is drawing close to an important milestone as the PDUFA date for its Twirla drug candidate is now right around the corner. The Food and Drug Administration is scheduled to announce its decision on February 16 th . The FDA was earlier supposed to pass the verdict...
In a recent piece , I reviewed what I see as fundamentally undervalued equity shares of Agile Therapeutics ([[AGRX]]) and the Twirla patch's strong chances of approval in the context of the product's February 16 PDUFA date. After this article was published, I dug into recent votes of the sa...
Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 141 weeks of public selections as part of this ongoing live forward-testing. In...
Agile Therapeutics, Inc. (AGRX) is a ~$160 million market capitalization biotechnology company that has had quite a wild ride over the last years. AGRX is a women's healthcare company that focuses on the development and commercialization of prescription contraceptive products for women. The ...
PRINCETON, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that the company will present at the 38 th Annual J.P. Morgan Healthcare Conference in San Francisco. Al Altomari, Chairman and Chief Executive O...
PRINCETON, N.J., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Kimberly Whelan as Vice President of Market Access. Ms. Whelan has over 35 years of experience in the healthcare industry worki...
Gainers: CLPS (NASDAQ: CLPS ) +68% . More news on: CLPS Incorporation, Microbot Medical Inc., Proteostasis Therapeutics, Inc., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Agile Therapeutics Inc. Company Name:
AGRX Stock Symbol:
OTCMKTS Market:
Agile Therapeutics Inc. Website:
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare com...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 Company Completes Pay-Off of Debt Facility in First Quarter 2024 Twirla Demand Expected to Rebound in First Quarter 2...